Guest guest Posted January 13, 2010 Report Share Posted January 13, 2010 http://www.fda.gov/medwatch/safety/2001/may01.htm#aquame AQUAMEPHYTON (phytonadione) Injection [May 18, 2001: Merck] Boxed WARNING Revisions in bolded, underlined italics - WARNING - INTRAVENOUS AND INTRAMUSCULAR USE Severe reactions, including fatalities, have occurred during and immediately after INTRAVENOUS injection of AquaMEPHYTON (Phytonadione), even when precautions have been taken to dilute the AquaMEPHYTON and to avoid rapid infusion. Severe reactions, including fatalities, have also been reported following INTRAMUSCULAR administration. Typically these severe reactions have resembled hypersensitivity or anaphylaxis, including shock and cardiac and/or respiratory arrest. Some patients have exhibited these severe reactions on receiving AquaMEPHYTON for the first time. Therefore the INTRAVENOUS and INTRAMUSCULAR routes should be restricted to those situations where the subcutaneous other routes are is not feasible and the serious risk involved is considered justified. ADVERSE REACTIONS: Revisions in bolded, underlined italics - Deaths have occurred after intravenous and intramuscular administration. (See Box Warning ) DOSAGE AND ADMINISTRATION Whenever possible, AquaMEPHYTON should be given by the subcutaneous [ " or intramuscular route " deleted] (See Box Warning). ********* http://www.vaccinetruth.org/page_7.htm Vitamin K package insert I'll send more on Vitamin K ******** http://gentlebirth.org/archives/eyeointm.html Newborn Eye Ointment http://www.unhinderedliving.com/eyeointment.html Neonatal Ocular Prophylaxis Newborn Eye Ointment -------------------------------------------------------- Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.